Erectile dysfunction decisions — 2025

The Board granted service connection for various conditions, including obstructive sleep apnea, left hip condition, GERD, irritable bowel syndrome, back condition, right knee condition, left ankle condition, right ankle condition, erectile dysfunction, and bilateral lower extremity radiculopathy, all secondary to the Veteran's service-connected bilateral foot/toe conditions.

The Board granted service connection for obstructive sleep apnea and dismissed the appeals for increased ratings and special monthly compensation, as well as withdrawal of the appeal for erectile dysfunction and allergic rhinitis.

The Board granted service connection for colon cancer status post abdominoperineal resection with residual colostomy and erectile dysfunction, finding that the Veteran's conditions are related to his service.

The Board remands the claims for service connection for pseudofolliculitis of the scalp, lumbar spine disability, tonsillitis, and erectile dysfunction due to a lack of compliance with previous remand instructions.

The Board granted service connection for residuals of prostate cancer and ED, secondary to the service-connected residuals of prostate cancer.

The Board denied the veteran's claims for increased ratings and initial compensable ratings for prostate cancer, erectile dysfunction, left lower extremity peripheral neuropathy, and right lower extremity peripheral neuropathy.

The Board remands the claims for service connection for various disorders, including an acquired psychiatric disorder, neck, back, headache, right ankle, right knee, right shoulder, and right elbow disorders, penile disorder (erectile dysfunction), and sleep apnea, to correct a pre-decisional error by verifying the Veteran's duty status in January 2017 and obtaining additional medical opinions.

The Veteran's psychiatric disability was granted a 100 percent rating, and special monthly compensation (SMC) at the housebound rate was also granted from March 31, 2011.

The Board granted service connection for prostate cancer and erectile dysfunction as secondary to the prostate cancer.

The Board denied an earlier effective date for service connection for erectile dysfunction and special monthly compensation (SMC) based on loss of use of a creative organ, as the evidence did not support entitlement to these benefits prior to January 9, 2020.

The Board granted an effective date of October 6, 2023, for the award of service connection for ED and SMC(k).

The veteran's appeal requests for service connection for migraines, obstructive sleep apnea, and erectile dysfunction were denied due to untimeliness of the appeals.

The Board denied the Veteran's claim for an initial compensable rating for erectile dysfunction, finding that the evidence did not support a penile deformity and thus no higher rating was warranted.

The Board granted service connection for erectile dysfunction as secondary to the Veteran's service-connected hypertension.

The Board granted service connection for right and left knee disabilities, while remanding the claims for low back, bilateral lower extremity radiculopathy/sciatica, erectile dysfunction, and insomnia disabilities.

The Board remands the issue of secondary service connection for erectile dysfunction to correct a pre-decisional duty-to-assist error.

The Board denied service connection for bilateral sensorineural hearing loss and remanded the claims for other conditions due to insufficient evidence.

The Board remands the claims for service connection for gastritis, frequent urination, and erectile dysfunction due to a need for additional evidence.

The Board denied an initial rating in excess of 70 percent for other specified trauma and stressor-related disorder with subclinical features of PTSD and major depressive disorder, as well as a compensable rating for erectile dysfunction. The remaining issues were remanded.

The Board dismissed the appeal for service connection of ED, and remanded the appeals for DMII with complications and diabetic nephropathy, both secondary to herbicide exposure.